share_log

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K:外國發行人報告
美股SEC公告 ·  2024/11/27 21:53

Moomoo AI 已提取核心訊息

Jeffs' Brands has entered into a binding Letter of Intent with Deliverz.AI to establish a joint venture for deploying AI-powered autonomous robotic solutions in US healthcare logistics. The partnership leverages Deliverz.AI's proven technology, currently operational at Israel's Sheba Medical Center, where their flagship robot Polly autonomously delivers chemotherapy drugs.Under the agreement, Deliverz.AI will provide proprietary robotics technology licensing for 50% JV equity, while Jeffs' Brands will invest $1 million for the remaining 50%. The investment will be structured in phases: $100,000 upon definitive agreement signing, $100,000 after securing first US pilot project, and $800,000 in installments through 2025.The joint venture aims to capitalize on the service robotics market, projected to grow from $41.5 billion in 2023 to $84.8 billion by 2028. Both parties commit to finalizing definitive agreements within 30 days, subject to due diligence and regulatory approvals.
Jeffs' Brands has entered into a binding Letter of Intent with Deliverz.AI to establish a joint venture for deploying AI-powered autonomous robotic solutions in US healthcare logistics. The partnership leverages Deliverz.AI's proven technology, currently operational at Israel's Sheba Medical Center, where their flagship robot Polly autonomously delivers chemotherapy drugs.Under the agreement, Deliverz.AI will provide proprietary robotics technology licensing for 50% JV equity, while Jeffs' Brands will invest $1 million for the remaining 50%. The investment will be structured in phases: $100,000 upon definitive agreement signing, $100,000 after securing first US pilot project, and $800,000 in installments through 2025.The joint venture aims to capitalize on the service robotics market, projected to grow from $41.5 billion in 2023 to $84.8 billion by 2028. Both parties commit to finalizing definitive agreements within 30 days, subject to due diligence and regulatory approvals.
Jeffs' Brands與Deliverz.AI簽訂了一份具有約束力的意向書,以建立合資公司,在美國醫療物流中部署人工智能驅動的自主機器人解決方案。該合作伙伴關係利用了Deliverz.AI在以色列謝巴醫療中心運營的經過驗證的科技,其旗艦機器人Polly自主交付化療藥物。根據協議,Deliverz.AI將提供專有機器人技術許可,以獲得50%的合資股權,而Jeffs' Brands將投資100萬美元用於剩餘的50%。這項投資將分階段進行:在最終協議簽署時投資10萬美元,在獲得第一個美國試點項目後投資10萬美元,並在2025年期間分期支付80萬美元。該合資企業旨在利用服務機器人市場,預計該市場將從2023年的415億美元增長到2028年的848億美元。雙方承諾在30天內完成最終協議,具體取決於盡職調查和監管批准。
Jeffs' Brands與Deliverz.AI簽訂了一份具有約束力的意向書,以建立合資公司,在美國醫療物流中部署人工智能驅動的自主機器人解決方案。該合作伙伴關係利用了Deliverz.AI在以色列謝巴醫療中心運營的經過驗證的科技,其旗艦機器人Polly自主交付化療藥物。根據協議,Deliverz.AI將提供專有機器人技術許可,以獲得50%的合資股權,而Jeffs' Brands將投資100萬美元用於剩餘的50%。這項投資將分階段進行:在最終協議簽署時投資10萬美元,在獲得第一個美國試點項目後投資10萬美元,並在2025年期間分期支付80萬美元。該合資企業旨在利用服務機器人市場,預計該市場將從2023年的415億美元增長到2028年的848億美元。雙方承諾在30天內完成最終協議,具體取決於盡職調查和監管批准。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息